Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

Pope, Melissa, Haase, Ashley T·2003·Nature Medicine

Cited by (354)

Items 201–300 of 354

  1. Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection
    Naveen K. Vaidya, Ruy Miguel Ribeiro, Pinghuang Liu, Barton F. Haynes, Georgia D. Tomaras, Alan S. Perelson · 2018 · Frontiers in Microbiology
  2. Herbal extracts and compounds active against herpes simplex virus
    Kenneth D. Thompson · 2006 · Advances in phytomedicine
  3. Localized Populations of CD8low/− MHC Class I Tetramer+ SIV-Specific T Cells in Lymphoid Follicles and Genital Epithelium
    Jung Joo Hong, Matthew R. Reynolds, Teresa L. Mattila, Aaron Hage, David I. Watkins, Christopher J. Miller, Pamela J. Skinner · 2009 · PLoS ONE
  4. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections
    Damjan S. Nikolic, Eduardo Garcia, Vincent Piguet · 2007 · Expert Review of Anti-infective Therapy
  5. Peptide and protein-based inhibitors of HIV-1 co-receptors
    Horst A. von Recum, Jonathan K. Pokorski · 2013 · Experimental Biology and Medicine
  6. HIV glycoprotein gp120 enhances mesenchymal stem cell migration by upregulating CXCR4 expression
    Lei Li, Ryan Z. L. Lim, Lawrence S.U. Lee, Nicholas S. Y. Chew · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  7. A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity
    Adonis A. Rubio, Maria V. Filsinger Interrante, Benjamin N. Bell, Clayton L. Brown, Theodora U. J. Bruun, Celia C. LaBranche, David C. Montefiori, Peter S. Kim · 2021 · Journal of Virology
  8. HIV/AIDS Vaccines: A Need for New Concepts?
    Marc P Girard, Geetha P. Bansal · 2008 · International Reviews of Immunology
  9. Application of nanotechnology for the development of microbicides
    Francis Brako, Suntharavathanan Mahalingam, Bahijja Tolulope Raimi‐Abraham, Duncan Q.M. Craig, Mohan J. Edirisinghe · 2016 · Nanotechnology
  10. Development of a Point-of-Care Assay for HIV-1 Viral Load Using Higher Refractive Index Antibody-Coated Microbeads
    Mazhar Sher, Benjamin Coleman, Massimo Caputi, Waseem Asghar · 2021 · Sensors
  11. Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice
    Jorma Hinkula, Marie Hagbom, Britta Wahrén, Ulf Schröder · 2008 · Vaccine
  12. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission
    Eric Armstrong, Rupert Kaul, Craig R. Cohen · 2022 · Journal of Internal Medicine
  13. HIV-1 Transmission, Replication Fitness and Disease Progression
    Tasha Biesinger, Jason T. Kimata · 2008 · Virology Research and Treatment
  14. A Nonneutralizing Anti-HIV-1 Antibody Turns into a Neutralizing Antibody When Expressed on the Surface of HIV-1-Susceptible Cells: A New Way to Fight HIV
    Seung‐Jae Lee, Laura Garza, Jun Yao, Abner Louis Notkins, Paul Zhou · 2004 · The Journal of Immunology
  15. Short Communication: Severe Immune Suppression in Patients Infected with R5-Tropic HIV-1 Strains Is Associated with Increased gp120 Net Charge at Variable Regions
    Eduardo Seclén, Vincent Soriano, María del Mar González, Juan González‐Lahoz, Eva Poveda · 2011 · AIDS Research and Human Retroviruses
  16. Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users
    Eveli Kallas, Kristi Huik, Merit Pauskar, Ene‐Ly Jõgeda, Tõnis Karki, Don Des Jarlais, Anneli Uusküla, Radko Avi, Irja Lutsar · 2014 · Infection Genetics and Evolution
  17. Pharmacokinetic evaluation of poorly soluble compounds formulated as nano- or microcrystals after intraperitoneal injection to mice
    Krishna Chaitanya Aluri, Kalle Sigfridsson, Aixiang Xue, Niresh Hariparsad, Dermot F. McGinnity, Diane Ramsden · 2023 · International Journal of Pharmaceutics
  18. HIV Reverse-Transcriptase Drug Resistance Mutations During Early Infection Reveal Greater Transmission Diversity Than in Envelope Sequences
    Jonathan T. Lipscomb, William M. Switzer, Jin-fen Li, Silvina Masciotra, Sherry Michele Owen, Jeffrey Allan Johnson · 2014 · The Journal of Infectious Diseases
  19. DC–T cell virological synapses and the skin: novel perspectives in dermatology
    Takatoshi Shimauchi, Vincent Piguet · 2014 · Experimental Dermatology
  20. Towards a Coronavirus‐Based HIV Multigene Vaccine
    Klara Eriksson, Divine Makia, Reinhard Maier, Burkhard Ludewig, Volker Thiel · 2006 · Journal of Immunology Research
  21. Role of Follicular Dendritic Cells in the Early HIV‐1 Infection: In vitro Model without Specific Antibody
    Midori Taruishi, Kazuo Terashima, Md. Zahidunnabi Dewan, Norio Yamamoto, Satoshi Ikeda, Daisuke Kobayashi, Yoshinobu Eishi, Momoko Yamazaki, Tohru Furusaka, Masahiro Sugimoto et al. · 2004 · Microbiology and Immunology
  22. Mucosal immunity and HIV/AIDS vaccines
    Marc P Girard, Geetha P. Bansal, Livia Pedroza-Martins, Betty Dodet, Vijay L Mehra, Marco L. Schito, Bonnie J. Mathieson, Jean‐François Delfraissy, James A. Bradac · 2008 · Vaccine
  23. Ex Vivo HIV Infection Model of Cervico-Vaginal and Rectal Tissue
    Louise A. Ouattara, Nikolas C. Vann, Gustavo F. Doncel · 2022 · Methods in molecular biology
  24. A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells
    Thomas Mourez, Mariana Mesel‐Lemoine, Chantal Combredet, Valérie Najburg, Nadège Cayet, Frédéric Tangy · 2011 · Virology
  25. Protein-Based HIV-1 Microbicides
    Barna Dey, Laurel A. Lagenaur, Paolo Lusso · 2014 · Current HIV Research
  26. Follicular Dendritic Cells Activate HIV-1 Replication in Monocytes/Macrophages through a Juxtacrine Mechanism Mediated by P-Selectin Glycoprotein Ligand 1
    Kenji Ohba, Akihide Ryo, Md. Zahidunnabi Dewan, Mayuko Nishi, Toshio Naito, Xiaohua Qi, Yoshio Inagaki, Yoji Nagashima, Yuetsu Tanaka, Takashi Okamoto et al. · 2009 · The Journal of Immunology
  27. Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with β2-adrenergic agonist
    Seong Bum Kim, Young Woo Han, Md. Masudur Rahman, Seon Ju Kim, Dong Jin Yoo, Seong Ho Kang, Koanhoi Kim, Seong Kug Eo · 2009 · Experimental & Molecular Medicine
  28. Vaginal Drug Delivery
    Emily A. Krogstad, Michael John Rathbone, Kim A. Woodrow · 2013 · Advances in delivery science and technology
  29. Human immunodeficiency virus type 1 impairs sumoylation
    B. Mete, Emre Pekbilir, B. Bilge, Panagiota Georgiadou, Elif Çelik, Tolga Sutlu, F. Tabak, Umut Şahin · 2022 · Life Science Alliance
  30. ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission.
    J. Biggins, Tasha Biesinger, Monica T. Yu Kimata, R. Arora, J. Kimata · 2007 · Virology
  31. The HIV-1 Tat Protein Enhances Megakaryocytic Commitment of K562 Cells by Facilitating CREB Transcription Factor Coactivation by CBP
    Christopher A. Williams, Debasis Mondal, Krishna C. Agrawal · 2005 · Experimental Biology and Medicine
  32. A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioning
    Soohyun Kim, Caelan E. Radford, Duo Xu, Jianing Zhong, Jonathan Do, Dominic M. Pham, Katie A. Travisano, Maria V. Filsinger Interrante, Theodora U. J. Bruun, Valerie K. Rezek et al. · 2025 · Nature Communications
  33. Human immunodeficiency virus transmission—Mechanisms underlying the cell‐to‐cell spread of human immunodeficiency virus
    Marta S. Calado, David Pires, Carolina M. Conceição, Quirina Santos‐Costa, Elsa Anes, José Miguel Azevedo‐Pereira · 2023 · Reviews in Medical Virology
  34. Hormonal influence on HIV ‐1 transmission in the female genital tract: New insights from systems biology
    Haley A. Dupont, Jeff Lam, Matthew William Woods, Muhammad Atif Zahoor, Charu Kaushic · 2018 · American Journal of Reproductive Immunology
  35. Anti HIV-1 Activity of the Crude Extracts of Guaiacum officinale L. (Zygophyllaceae)
    Henry I. C. Lowe · 2014 · European Journal of Medicinal Plants
  36. Plasma and Mucosal Fluid from HIV Type 1-Infected Patients But Not from HIV Type 1-Exposed Uninfected Subjects Prevent HIV Type 1-Exposed DC from Infecting Other Target Cells
    Johan Söderlund, Taha Hirbod, Anna Smed‐Sörensen, Ulrika Johansson, Joshua Kimani, Francis Allan Plummer, Anna‐Lena Spetz, Jan Andersson, Rupert Kaul, Kristina Broliden · 2007 · AIDS Research and Human Retroviruses
  37. Investigating widely available substances as vaginal microbicides
    Wendy R Holmes · 2004 · Sexual Health
  38. Attachment and Fusion Inhibitors Potently Prevent Dendritic Cell-Driven HIV Infection
    Ines Frank, Melissa Robbiani · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  39. Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1
    Ho‐Hsien Lee, Irene Cherni, Hongqi Yu, Raimund Fromme, Jeffrey D. Doran, Ingo Grotjohann, Michele Mittman, Shibom Basu, Arpan Deb, Katerina Dörner et al. · 2014 · IUCrJ
  40. Mucosal antibodies induced by tandem repeat of 2F5 epitope block transcytosis of HIV-1
    Ji Wang, Liling Xu, Pei Tong, Yinghua Chen · 2011 · Vaccine
  41. Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)
    Narenda Kumar, Rajiv Kumar · 2014 · Elsevier eBooks
  42. Qualitative and Quantitative Intravaginal Targeting: Key to Anti-HIV-1 Microbicide Delivery from Test Tube to In Vivo Success
    Viness Pillay, Felix Mashingaidze, Yahya Essop Choonara, Lisa C. du Toit, Eckhart Buchmann, Vinesh Jaichand Maharaj, Valence M. K. Ndesendo, Pradeep Kumar · 2012 · Journal of Pharmaceutical Sciences
  43. How fast could HIV change gene frequencies in the human population?
    Deborah Cromer, Steven M. Wolinsky, Angela Ruth McLean · 2010 · Proceedings of the Royal Society B Biological Sciences
  44. Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses
    Hongbing Yang, Anuska Llano, Samandhy Cedeño, Annette von Delft, Angelica Corcuera, Geraldine M. A. Gillespie, Andrew Alexander Knox, Darren B. Leneghan, John Frater, Wolfgang Stöhr et al. · 2020 · Cell Reports
  45. HIV-1, Neuro-AIDS and Cognitive Impairments
    Bechan Sharma · 2014
  46. Environmental Factors in HIV/AIDS Epidemic Development: New Perspectives for Gender Equity and Global Protection against HIV Transmission
    Annette Alfsen · 2004 · Annals of the New York Academy of Sciences
  47. Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form
    Aditya Pattani, Paul F. McKay, Rhonda M. Curran, Joanne McCaffrey, Prem Narayan Gupta, Deborah Lowry, Victoria L. Kett, Robin J. Shattock, Helen O. McCarthy, Karl R. Malcolm · 2012 · Vaccine
  48. Sleeping with the Enemy: The Insidious Relationship between Dendritic Cells and Immunodeficiency Viruses
    Laurence Vachot, Stuart Grant Turville, S. Trapp, Silvia Peretti, George W. Morrow, Ian Frank, Melissa Pope · 2006
  49. Innate and adaptive immunity in the human female reproductive tract: influence of the menstrual cycle and menopause on the mucosal immune system in the uterus
    Charles R. Wira, John V. Fahey, Todd M. Schaefer, Patricia Ann Pioli, Charles L. Sentman, Li Shen · 2008 · Reproductive medicine and assisted reproductive techniques series
  50. Virological Synapse for Cell-Cell Spread of Viruses
    Eduardo Garcia, Vincent Piguet · 2006 · Springer eBooks
  51. PREDICTING THE PROBABILITY OF PERSISTENCE OF HIV INFECTION WITH THE STANDARD MODEL
    Henry C. Tuckwell, Patrick D. Shipman · 2011 · Journal of Biological Systems
  52. The Incubation Period of Acute Retroviral Syndrome as a Multistep Process
    Philippe Vanhems, Nicolas Voirin, Pierre Philippe, Bernard J. Hirschel, Joëlle Brassard, Andrew D Carr, David A. Cooper, Luc H. Perrin, Robert Allard · 2004 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  53. A Nonneutralizing Anti-HIV Type 1 Antibody Turns into a Broad Neutralizing Antibody When Expressed on the Surface of HIV Type 1-Susceptible Cells. II. Inhibition of HIV Type 1 Captured and Transferred by DC-SIGN
    Seung‐Jae Lee, Reetakshi Arora, Lara Bull–Otterson, Roberto C. Arduino, Laura Garza, Jonathan S. Allan, Jason T. Kimata, Paul Zhou · 2006 · AIDS Research and Human Retroviruses
  54. Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep Pyrosequencing
    For Yue Tso, Damien C. Tully, Sandra Milena González, Christopher Quince, On Ho, Patricia S. Polacino, Ruth M. Ruprecht, Shiu‐Lok Hu, Charles A. Wood · 2012 · PLoS ONE
  55. Evaluation of the lymphocyte trafficking drug FTY 720 in vaginal tissues
    Ai Tsuiki, Wei Luo, Tara Henning, Sundaram Ajay Vishwanathan, Chuong T. Dinh, Debra Adams, Elizabeth Sweeney, James Michael Mitchell, Shannon Bachman, Prachi Sharma et al. · 2013 · Journal of Medical Primatology
  56. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies
    Soohyun Kim, Maria V. Filsinger Interrante, Peter S. Kim · 2022 · Journal of Virology
  57. HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier
    Benjamin N. Bell, Theodora U. J. Bruun, Natalia Friedland, Peter S. Kim · 2023 · Proceedings of the National Academy of Sciences
  58. Modelling the risk of HIV infection for drug abusers
    Angelica Bloomquist, Naveen K. Vaidya · 2020 · Journal of Biological Dynamics
  59. Simian Immunodeficiency Virus Infection and Mucosal Immunity
    Huanbin Xu, Xiaolei Wang, Ronald S. Veazey · 2015 · Elsevier eBooks
  60. Bovine alpha-2-HS-glycoprotein functions as a booster antigen for efficiently stimulating humoral immune responses to CCR5 and SIVmac239 envelope glycoprotein
    Yasuharu Otsubo, Seizo Yashiro, Kiyoteru Nozaki, Kaoru Matsuura, Kouhei Kiyonaga, Ryotarou Mitsumata, Yoshihiro Takahashi, Mitsuaki Masuyama, Atsunobu Muneoka, Nobutoki Takamune et al. · 2013 · Biochemical and Biophysical Research Communications
  61. Genotypic Characterization of HIV Type 1 in Jamaica
    Marcia E. Roye, Icolyn I. Amarakoon, Cindy-Leigh C. Hamilton, Lindsay M. Eyzaguirre, Peter Figueroa, Jean K. Carr · 2010 · AIDS Research and Human Retroviruses
  62. The R5 to X4 Coreceptor Switch: A Dead-End Path, or a Strategic Maneuver?
    Sharon Anne Bewick, Jing Qin Wu, Scott C. Lenaghan, Ruoting Yang, Mingjun Zhang, William R. Hamel · 2011 · Bulletin of Mathematical Biology
  63. Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection
    Qingsheng Li, Pamela J. Skinner, Sang‐Jun Ha, Lijie Duan, Teresa L. Mattila, Aaron Hage, Cara White, Daniel L. Barber, Leigh A. O’Mara, Peter J. Southern et al. · 2009 · Science
  64. КРИТЕРИИ ДЛЯ ИНДУКЦИИ НЕЙТРАЛИЗУЮЩИХ АНТИТЕЛ ШИРОКОГО СПЕКТРА ДЕЙСТВИЯ ПРОТИВ ВИЧ-1 С ПОМОЩЬЮ ВАКЦИНАЦИИ, "Молекулярная биология"
    Andrei N. Vzorov, Uryvaev Lv · 2017 · Molecular Biology
  65. Evaluation of intravirion human immunodeficiency virus type 1 RNA degradation activity in saliva by an RNA cleavage quantification method
    Masaaki Murayama, Sayaka Yamazaki, Eiko Yamada, Ryo Ikeno, Masaki Nagata, Ritsuo Takagi, Shingo Kato · 2019 · Oral Science International
  66. Dendritic cell-mediated HIV-1 transmission
    Fedde Groot · 2006 · UvA-DARE (University of Amsterdam)
  67. Anatomical and Hormonal Influences on Women's Dermatologic Health
    June K. Robinson · 2006 · JAMA
  68. Parenteral Inhibitors of HIV Entry in Current Development
    Jacob Paul Lalezari, Stanley T. Lewis, G. Mani Subramanian, Richard Krawiec, Mary K. Delmedico, Zhu‐Nan Li, David A. Steinhauer, Per Johan Klasse, Graeme J Moyle · 2006
  69. Endocervix exhibits greater susceptibility to HIV-1 infection compared to ectocervix following ex vivo exposure to Transmitted/Founder HIV-1 variants
    Robert Langat, Michael D. McRaven, Ramón Lorenzo-Redondo, Teresia Muhomah, Ann M. Carias, Muhammad Shoaib Arif, Matrona Akiso, Marianne Mureithi, Omu Anzala, Jill W Gilmour et al. · 2025 · PLoS ONE
  70. HIV Envelope-Specific Antibody and Vaccine Efficacy
    Egidio Brocca‐Cofano, Peng Xiao, Marjorie Robert-Guroff · 2011 · InTech eBooks
  71. Studies on the cellular factors and hormones controlling HIV-1 transmission in an organ culture model
    Soni Ramachandra Sankapal · 2015 · D-Scholarship@Pitt (University of Pittsburgh)
  72. HSV Type 2 Infection Increases HIV DNA Detection in Vaginal Tissue of Mice Expressing Human CD4 and CCR5
    M. Reza Zariffard, Mohammed Saifuddin, Alison Finnegan, Gregory T. Spear · 2009 · AIDS Research and Human Retroviruses
  73. Diversity of Trends of Viremia and T-Cell Markers in Experimental Acute Feline Immunodeficiency Virus Infection
    Sylvain Roche, Hanane El Garch, Sylvie Brunet, Hervé Poulet, Jean Iwaz, René Écochard, Philippe Vanhems · 2013 · PLoS ONE
  74. Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression
    For Yue Tso, Levon G. Abrahamyan, Shiu-Lok Hu, Ruth M. Ruprecht, Charles A. Wood · 2013 · PLoS ONE
  75. Resistance Against Inhibitors of HIV-1 Entry into Target Cells
    Victor G. Kramer, Mark A. Wainberg · 2015 · Future Virology
  76. Viral (HIV) Entry: How Does It Work?
    George Z. Panos, Mark Richard Nelson · 2008 · Springer eBooks
  77. Human Immunodeficiency Viruses Types 1 and 2
    Richard A. Kaslow, Emily J. Erbelding, Paul Goepfert · 2014 · Springer eBooks
  78. From Individuals to Populations: Immunological and Epidemiological Significance of Co-infection in the Dynamics of HIV
    Diego F. Cuadros · 2013 · Journal of Clinical & Cellular Immunology
  79. Mechanism for HIV invasion via skin or mucosa
    Tatsuyoshi Kawamura · 2011 · Uirusu
  80. CD4 Count of Art and Non-Art Hiv Positive Patients Attending Living Word Mission Hospital Abayi Aba, Abia State, Nigeria
    Emmanuel Ifeanyi Obeagu, Okoroiwu Ijeoma Leticia, Ochei Kingsley Chinedum, Okoro Nnenna Kalu, Chikwendu Lawrence Udenze · 2014 · IOSR Journal of Dental and Medical Sciences
  81. STABILIZATION OF GP120 OUTER DOMAIN FOR HIV-1-1 VACCINE IMMUNOGEN DESIGN
    Duoyi Hu · 2016 · Lincoln (University of Nebraska)
  82. Early phase dynamics of traceable mCherry fluorescent protein-carrying HIV-1 infection in human peripheral blood mononuclear cells-transplanted NOD/SCID/Jak3 -/- mice
    Nobuyo Higashi‐Kuwata, Hiromi Ogata-Aoki, Shin-ichiro Hattori, Hironori Hayashi, Matthew L. Danish, Manabu Aoki, Chiemi Shiotsu, Tatsuyoshi Kawamura, Hironobu Ihn, Hisataka Kobayashi et al. · 2017 · Antiviral Research
  83. HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugs
    Fan Li, Liying Ma, Yi Feng, Yuhua Ruan, Jing Hua Hu, Hongshuo Song, Pengtao Liu, Jun Ma, Baolin Rui, Kate Kerpen et al. · 2017 · AIDS
  84. HIV Transmission and its Prevention in Asia
    Stephen John Kerr, Kiat Ruxrungtham · 2008 · Elsevier eBooks
  85. Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination
    Andrei N. Vzorov, Uryvaev Lv · 2017 · Molecular Biology
  86. Mucosal and systemic immune responses in HIV-1 exposed uninfected individuals
    Klara Hasselrot · 2009 · Figshare
  87. Les mécanismes de résistance à la transmission sexuelle du VIH-1
    A. Eberhard, Bénédicte Ponceau, François Biron, Bernard Verrier · 2005 · Médecine et Maladies Infectieuses
  88. HIV-1 PHENOTYPE AND GENETIC VARIATION IN VERTICAL TRANSMISSION
    Peter Clevestig · 2006 · Figshare
  89. Semen-mediated Enhancement of HIV Infection Markedly Impairs the Antiviral Efficacy of Microbicides
    Onofrio Zirafi, Kyeong-Ae Kim, Nadia R. Roan, Benjamin Mayer, Silvia F. Kluge, Shibo Jiang, Warner C. Greene, Frank Kirchhoff, Jan Münch · 2014 · AIDS Research and Human Retroviruses
  90. Responding with Treatment to Those Acutely Infected with HIV: No Time to Lose
    Peter A. Leone · 2006 · North Carolina Medical Journal
  91. HIV-1 Entry Inhibitor Resistance
    Victor G. Kramer, Mark A. Wainberg · 2014 · Springer eBooks
  92. Immunology in the Era of HIV/AIDS
    Deborah Jean Anderson · 2005 · Elsevier eBooks
  93. THE ROLE OF MUCOSAL EPITHELIAL CELLS IN HIV-1 INFECTION
    Danielle Fontenot · 2010 · Digital Commons-TMC (Texas Medical Center)
  94. Evolution of human immunodeficiency virus type 1 clade C envelope V1-V5 region during disease progression in non-human primate model
    For Yue Tso · 2013 · Lincoln (University of Nebraska)
  95. Improving the immunogenicity of HIV-1 DNA vaccines.
    David Hallengärd · 2010 · Figshare
  96. Follicular Dendritic Cells, Human Immunodeficiency Virus Type-1, And Alpha-1-Antitrypsin
    Xueyuan Zhou · 2012
  97. HIV-1 Envelope-Induced Signaling Mediates Actin Cytoskeleton Rearrangements Necessary for Fusion and Entry
    Brooke Harmon · 2009 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  98. Ligand-induced structural changes in HIV-1 envelope glycoprotein
    Selina Poon · 2013 · Figshare
  99. Excreção cervicovaginal do vírus da imunodeficiência humana (HIV) ao longo do ciclo menstrual em mulheres soropositivas acompanhadas em serviço especializado de São Paulo
    Carla Andreia Baggetti Ferraz de Lima · 2008
  100. STUDY OF HIV-1 TRANSMISSION ACROSS HUMAN CERVICAL TISSUE TO THE LYMPHOID TISSUE USING AN ORGAN CULTURE MODEL
    Jackeline Soto‐Rivera · 2008 · D-Scholarship@Pitt (University of Pittsburgh)